Assessing Atopic Dermatitis severity in children from Georgia: the correlation of inflammatory blood markers to the

Janadi Karawita1, Faiza Yasmine Kabachi1, Aliya Modak1

  • 1Faculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia.

Insights

Eosinophil Relative Count (ERC) and Eosinophil/Lymphocyte Ratio (ELR) show potential as blood markers for atopic dermatitis (AD) severity in children. Further research is needed to confirm their clinical utility in assessing AD activity.

Area of Science:

  • Pediatric Dermatology
  • Immunology
  • Clinical Research

Background:

  • Atopic dermatitis (AD) is a widespread chronic inflammatory skin condition in children.
  • Systemic inflammation plays a crucial role in AD pathophysiology.
  • Identifying reliable blood markers can aid in assessing AD severity and guiding treatment.

Purpose of the Study:

  • To investigate the correlation between specific blood inflammatory markers and the Eczema Area and Severity Index (EASI) in pediatric patients with AD.
  • To evaluate the potential of Eosinophil Relative Count (ERC), Neutrophil/Lymphocyte Ratio (NLR), Eosinophil/Lymphocyte Ratio (ELR), and Basophil/Lymphocyte Ratio (BLR) as objective indicators of AD severity.

Main Methods:

  • A retrospective analysis of 22 pediatric patients diagnosed with AD.
  • Blood parameters including ERC, NLR, ELR, and BLR were measured.
  • These markers were statistically correlated with EASI scores.

Main Results:

  • A significant positive correlation was found between EASI scores and both ERC (r=0.69, p<0.001) and ELR (r=0.71, p<0.001).
  • No statistically significant correlation was observed between EASI scores and NLR (r=0.2059, p=0.3578) or BLR (r=0.1026, p=0.6494).
  • Age was not found to be significantly associated with EASI scores (r=-0.0351, p=0.8767).

Conclusions:

  • ERC and ELR demonstrate potential as objective blood biomarkers for evaluating the severity of atopic dermatitis in children.
  • Larger-scale studies in pediatric populations are recommended to establish a definitive association for clinical application.
Abstract